The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigating denosumab as add-on neoadjuvant treatment for hormone receptor-negative, RANK-positive or RANK-negative primary breast cancer and two different nab-Paclitaxel schedules - 2x2 factorial design (GeparX).
 
Sherko Kümmel
Honoraria - Amgen; Celgene; Genomic Health; Novartis; Roche
Consulting or Advisory Role - Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Gunter Von Minckwitz
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst)
 
Valentina Nekljudova
No Relationships to Disclose
 
Serban Dan Costa
No Relationships to Disclose
 
Carsten Denkert
No Relationships to Disclose
 
Claus Hanusch
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca; Novartis
Speakers' Bureau - AstraZeneca; Eisai; Novartis
Travel, Accommodations, Expenses - Novartis
 
Jens Bodo Huober
Consulting or Advisory Role - Amgen
Speakers' Bureau - Celgene
 
Christian Jackisch
No Relationships to Disclose
 
Stefan Paepke
No Relationships to Disclose
 
Jens Uwe Blohmer
No Relationships to Disclose
 
Michael Untch
No Relationships to Disclose
 
Andreas Schneeweiss
Honoraria - Celgene; Roche
Research Funding - Celgene
Travel, Accommodations, Expenses - Celgene; Roche
 
Sibylle Loibl
No Relationships to Disclose